133 related articles for article (PubMed ID: 9334290)
21. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
Podsypanina K; Li Y; Varmus HE
BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
[TBL] [Abstract][Full Text] [Related]
22. Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.
Huang S; Podsypanina K; Chen Y; Cai W; Tsimelzon A; Hilsenbeck S; Li Y
Technol Cancer Res Treat; 2006 Dec; 5(6):565-71. PubMed ID: 17121432
[TBL] [Abstract][Full Text] [Related]
23. Involvement of Notch1 in the development of mouse mammary tumors.
Diévart A; Beaulieu N; Jolicoeur P
Oncogene; 1999 Oct; 18(44):5973-81. PubMed ID: 10557086
[TBL] [Abstract][Full Text] [Related]
24. MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation.
Schroeder JA; Masri AA; Adriance MC; Tessier JC; Kotlarczyk KL; Thompson MC; Gendler SJ
Oncogene; 2004 Jul; 23(34):5739-47. PubMed ID: 15221004
[TBL] [Abstract][Full Text] [Related]
25. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
26. Stem cells and mammary cancer in mice.
Smith GH
Stem Cell Rev; 2005; 1(3):215-23. PubMed ID: 17142858
[TBL] [Abstract][Full Text] [Related]
27. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
[TBL] [Abstract][Full Text] [Related]
28. Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis.
Mack DL; Boulanger CA; Callahan R; Smith GH
Breast Cancer Res; 2007; 9(4):R42. PubMed ID: 17626637
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.
Tekmal RR; Ramachandra N; Gubba S; Durgam VR; Mantione J; Toda K; Shizuta Y; Dillehay DL
Cancer Res; 1996 Jul; 56(14):3180-5. PubMed ID: 8764102
[TBL] [Abstract][Full Text] [Related]
30. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
[TBL] [Abstract][Full Text] [Related]
31. Novel common integration sites targeted by mouse mammary tumor virus insertion in mammary tumors have oncogenic activity.
Kim HH; van den Heuvel AP; Schmidt JW; Ross SR
PLoS One; 2011; 6(11):e27425. PubMed ID: 22087314
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutations that contribute to breast cancer.
Callahan R
Biochem Soc Symp; 1998; 63():211-21. PubMed ID: 9513725
[TBL] [Abstract][Full Text] [Related]
33. Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.
Blanco-Aparicio C; Pérez-Gallego L; Pequeño B; Leal JF; Renner O; Carnero A
Carcinogenesis; 2007 Mar; 28(3):584-94. PubMed ID: 17050554
[TBL] [Abstract][Full Text] [Related]
34. Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer.
Lawson JS; Tran DD; Ford C; Rawlinson WD
Breast Cancer Res Treat; 2004 Sep; 87(1):13-7. PubMed ID: 15377846
[TBL] [Abstract][Full Text] [Related]
35. Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis.
Erny KM; Peli J; Lambert JF; Muller V; Diggelmann H
Oncogene; 1996 Nov; 13(9):2015-20. PubMed ID: 8934549
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.
Hu C; Diévart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P
Am J Pathol; 2006 Mar; 168(3):973-90. PubMed ID: 16507912
[TBL] [Abstract][Full Text] [Related]
37. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
38. Of mice and Myc: c-Myc and mammary tumorigenesis.
Jamerson MH; Johnson MD; Dickson RB
J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):27-37. PubMed ID: 15082916
[TBL] [Abstract][Full Text] [Related]
39. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
